| dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
| dc.contributor.author | Biagetti Biagetti, Betina |
| dc.contributor.author | Simó Canonge, Rafael |
| dc.date.accessioned | 2022-11-03T13:25:42Z |
| dc.date.available | 2022-11-03T13:25:42Z |
| dc.date.issued | 2022-08-05 |
| dc.identifier.citation | Biagetti B, Simò R. Pituitary Apoplexy: Risk Factors and Underlying Molecular Mechanisms. Int J Mol Sci. 2022 Aug 5;23(15):8721. |
| dc.identifier.issn | 1422-0067 |
| dc.identifier.uri | https://hdl.handle.net/11351/8388 |
| dc.description | Apoplexy; Growth factors; Matrix metalloproteinase |
| dc.description.abstract | Pituitary apoplexy is a rare syndrome, graded from asymptomatic subclinical apoplexy to a life-threatening condition due to pituitary ischemia or haemorrhage of an enlarged pituitary gland. The risk factors and the molecular underlying mechanisms are yet to be elucidated. We provide an overview of the general concepts, the potential factors associated with pituitary adenoma susceptibility for apoplectic events and the molecular mechanisms that could be involved such as HIF-1α/VEGF pathways and metalloproteinases activation, among others. The knowledge of the molecular mechanisms that could participate in the pathogenesis of pituitary apoplexy is crucial to advancement in the identification of future diagnostic tools and therapeutic targets in this rare but sometimes fatal condition. |
| dc.language.iso | eng |
| dc.publisher | MDPI |
| dc.relation.ispartofseries | International Journal of Molecular Sciences;23(15) |
| dc.rights | Attribution 4.0 International |
| dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
| dc.source | Scientia |
| dc.subject | Hipòfisi - Necrosi |
| dc.subject | Malalties cerebrovasculars - Factors de risc |
| dc.subject | Adenoma |
| dc.subject.mesh | Pituitary Apoplexy |
| dc.subject.mesh | /complications |
| dc.subject.mesh | Risk Factors |
| dc.subject.mesh | Adenoma |
| dc.title | Pituitary Apoplexy: Risk Factors and Underlying Molecular Mechanisms |
| dc.type | info:eu-repo/semantics/article |
| dc.identifier.doi | 10.3390/ijms23158721 |
| dc.subject.decs | apoplejía hipofisaria |
| dc.subject.decs | /complicaciones |
| dc.subject.decs | factores de riesgo |
| dc.subject.decs | adenoma |
| dc.relation.publishversion | https://doi.org/10.3390/ijms23158721 |
| dc.type.version | info:eu-repo/semantics/publishedVersion |
| dc.audience | Professionals |
| dc.contributor.organismes | Institut Català de la Salut |
| dc.contributor.authoraffiliation | Unitat de Recerca en Diabetis i Metabolisme, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain |
| dc.identifier.pmid | 35955859 |
| dc.identifier.wos | 000838924200001 |
| dc.rights.accessrights | info:eu-repo/semantics/openAccess |